Anti-Aging Therapeutics Volume XVII. A4M American Academy

Чтение книги онлайн.

Читать онлайн книгу Anti-Aging Therapeutics Volume XVII - A4M American Academy страница 3

Автор:
Жанр:
Серия:
Издательство:
Anti-Aging Therapeutics Volume XVII - A4M American Academy

Скачать книгу

with $1 billion in start-up funding. Describing its goal as “focusing on the challenge of aging and associated diseases.” Page has observed that: “With some longer term, moonshot thinking around healthcare and biotechnology, I believe we can improve millions of lives.”1 Calico is headed by Art Levinson, former CEO of Genetech, a highly successful biotech company specializing in cancer therapies.

      In mid-2014, Calico forged a 10-year R&D collaboration deal with AbbVie Inc., a major US drugmaker (notably, Humira®, a rheumatoid arthritis biologic).2 Each company is reported to invest an initial $250 million, with a possible additional $500 million in the future. Using this funding, Calico will use its scientific expertise to establish a world-class research and development facility and AbbVie will use its commercial expertise to bring the new drugs discovered in this facility to market.

      In early 2014, US scientist Craig Venter, who mapped the Human Genome a decade ago, founded Human Longevity, Inc.1 With $70 million in its first round of private funding and prominent Asian real estate developers as key investors, the company aims to take a genome-based approach “to tackle the diseases associated with aging-related human biological decline.”

      In 2015, The Pharma division of Johnson & Johnson, Janssen Research & Development, announced its investment of billions of dollars towards 3 research projects to “prevent illnesses – particularly relating to aging and lifestyle.”3

      Today’s tech billionaires are seeking to cheat death:

      Peter Thiel (Paypal, Facebook) is now age 47. Thiel’s Breakout Labs “aims to support early-stage companies that push the boundaries of what’s possible”, as he considers “death [as] humanity’s greatest enemy." He has stated that: “Almost every major disease is linked to aging. At the end of the day, we need to do more. A tiny fraction of a fraction of a fraction of NIH [National Institutes of Health] spending goes to genuine anti-aging research.”4

      Larry Ellison (Oracle) is investing $430 million because “death has never made any sense to me.” Sergey Brin (Google) has committed $150 million to DNA data mining.5

      CONCLUDING REMARKS

      Silicon Valley and Fortune 500 companies commit over US $6 Billion to efforts to reveal effective therapies to reverse and cure aging. These significant funds must not be squandered, as was the $1 Trillion spent on the War on Cancer of the 1970s – that yielded limited applicable discoveries. The public must demand, and expect transparency in human aging intervention so that breakthroughs are shared with the public without delay and without obfuscation, and without the political agendas that continue to thwart true innovation and rapid advances seen in other scientific fields such as physics, microelectronics and computing – but seemingly withheld by establishment medicine,

      A4M wrote the history of longevity medicine and remains positioned to lead the clinical specialty via its educational programming. The entirely novel marketplace of anti-aging, which stood at zero dollars prior to 1991 (the year A4M was established), is valued at $250 Billion (2012). The sector is projected to grow at a compound annual growth rate of 5.7%, to top $345 billion in 2018.6

      REFERENCES

      1."Anti-ageingdrugs may have been developed,” Independent,co.uk, 2 October 2014.

      2.Google’s Calico, AbbVie forge deal against diseases of aging,” Reuters.com. 3 September 2014. Can Google’s Calico develop a cure for death?” Nanlyze.com, 4 September 2014

      3.“Johnson & Johnson projects aim to spot who’ll get a disease,” MedicalXpress.com, 12 Feb. 2015.

      4.“Tech billionaires are trying to defeat death,” uk.BusinessInsider.com, 17 April 2015. “A contrarian in Biotech,” MIT Technology Review, 16 March 2015. “Peter Thiel’s quest to find the key to eternal life,” Washington Post, 3 April 2015.

      5.“Tech billionaires are trying to defeat death,” uk.BusinessInsider.com, 17 April 2015.

      6.”BCC Research Publishes A New Report on Global Markets for Antiaging Products and Services,” PR Web, Sept. 17, 2013.

      ABOUT THE AUTHOR

      Dr. Ronald Klatz, M.D., D.O. is a physician, medical scientist, futurist, and innovator. He coined the term "anti-aging medicine" and is recognized as a leading authority in the new clinical science of anti-aging medicine. Dr. Klatz is the physician founder and President of the American Academy of Anti-Aging Medicine – A4M. Since 1981, Dr. Klatz has been integral in the pioneering exploration of new therapies for the treatment and prevention of age-related degenerative diseases. He is the inventor, developer, or administrator of 100-plus scientific patents, including those for technologies for brain resuscitation, trauma and emergency medicine, organ transplant and blood preservation. Today, Dr. Klatz helps to support aging-related biotech research and supervises postgraduate medical training programs for physicians from 120 countries. A best-selling author and columnist, Dr. Klatz is Medical Editor for The World Health Network – the A4M’s educational website at www.worldhealth.net.

      Chapter 2

      Energy Medicine Going Mainstream

      Silvia Binder, ND, Ph.D.

      President, Ondamed Companies Germany & New York;

      Founder, The Binder Institute for Personalized Medicine

      ABSTRACT

      Energy is the substance of life. Without the understanding of energy, medical professionals cannot possibly comprehend the significant role that energy plays in medicine. We could not imagine a hospital today without the diagnostic capabilities of X-Ray, MRI, EEG, and EKG. All of these techniques measure and report the energy of a particular part of the body. The author’s hope is that this article will widen the reader’s perspective, understanding, and use of Energy Medicine which, ideally, should complement patient care.

      Keywords: Energy Medicine, Electromagnetism, Biofeedback, Focused Field Stimulation, Personalized Medicine, Mind-Body Medicine

      INTRODUCTION

      “If you want to find the secrets of the universe, think in terms of energy, frequency and vibration.”

      -- Nikola Tesla

      Energy medicine is the diagnostic and therapeutic use of energy whether produced by or detected by a medical device or by the human body. Energy medicine recognizes that the human body utilizes various forms of energy for communications involved in physiological regulations. Energy medicine involves energy of particular frequencies and intensities and wave shapes that stimulate the repair of one or more tissues. Examples of energy include heat, light, sound, gravity, pressure, vibration, electricity, magnetism, chemical energy, and electromagnetism.1

      It may come as a surprise to many to learn that energy medicine has been part of human history for thousands of years. Ever since man crawled and later walked the earth, energy was an essential part of primitive societies as well as advanced sophisticated cultures, including the Egyptians, the Chinese and the Greeks.

      Going back

Скачать книгу